← All Posts
QUE
Quest Diagnostics Incorporated
May 21, 2026
•
Author: Phil Ratcliff
| Item |
Proposal |
Vote |
| 1 |
Election of Directors |
|
| 1a |
Robert B. Carter |
✓ For(0.384)
|
| 1b |
James E. Davis |
✗ Against(0.384)
|
| 1c |
Luis A. Diaz, Jr., M.D. |
✓ For(0.384)
|
| 1d |
Tracey C. Doi |
✓ For(0.384)
|
| 1e |
Vicky B. Gregg |
✓ For(0.384)
|
| 1f |
Wright L. Lassiter, III |
✓ For(0.384)
|
| 1g |
Timothy L. Main |
✓ For(0.384)
|
| 1h |
Denise M. Morrison |
✓ For(0.384)
|
| 1i |
Gary M. Pfeiffer |
✓ For(0.384)
|
| 1j |
Timothy M. Ring |
✓ For(0.384)
|
| 1k |
Timothy C. Wentworth |
✓ For(0.384)
|
| 2 |
An advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 proxy statement. |
✓ For(0.384)
|
| 3 |
Ratification of the appointment of our independent registered public accounting firm for 2026. |
✓ For(0.384)
|
| 4 |
Stockholder proposal regarding an independent board chairman, if properly presented at the Annual Meeting. |
✗ Against(0.384)
|
This article was written for information purposes only and its content should not be
construed by any consumer and/or prospective client as rebel Financial's solicitation
to affect, or attempt to affect transactions in securities, or the rendering of
personalized investment advice for compensation. No client or prospective client should
assume that any such discussion serves as the receipt of, or a substitute for,
personalized advice from rebel Financial, or from any other investment professional.
See our disclosures page for more information.